We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

49 hedge funds and large institutions have $619M invested in Korro Bio in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 2

105% more capital invested

Capital invested by funds: $302M → $619M (+$317M)

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

23% more funds holding

Funds holding: 40 → 49 (+9)

4.13% more ownership

Funds ownership: 82.03% → 86.16% (+4.1%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $9K

Holders
49
Holders Change
+9
Holders Change %
+22.5%
% of All Funds
0.71%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
12
Reduced
9
Closed
2
Calls
–
Puts
$9K
Net Calls
-$9K
Net Calls Change
-$11K

Top Buyers

1
Verition Fund Management
Verition Fund Management
Connecticut
+$4.48M
2
Invesco
Invesco
Georgia
+$3.95M
3
Millennium Management
Millennium Management
New York
+$3.32M
4
Goldman Sachs
Goldman Sachs
New York
+$2.47M
5
ECM
ExodusPoint Capital Management
New York
+$1.93M

Top Sellers

1
MIM
Monashee Investment Management
Massachusetts
-$1.93M
2
EAM
Eventide Asset Management
Massachusetts
-$482K
3
BlackRock
BlackRock
New York
-$273K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$235K
5
Morgan Stanley
Morgan Stanley
New York
-$233K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$101M – – –
NMC
2
NEA Management Company
Maryland
$96.6M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$63.4M – – –
EAM
4
Eventide Asset Management
Massachusetts
$48.4M -$482K -8,835 -2%
CAM
5
Cormorant Asset Management
Massachusetts
$47.6M – – –
Citadel Advisors
6
Citadel Advisors
Florida
$46.4M +$382 +7 +0%
AG
7
Artal Group
Luxembourg
$37.7M +$33.9K +621 +0.1%
QUSVM
8
Qiming U.S. Ventures Management
Washington
$33.1M – – –
7IH
9
72 Investment Holdings
Connecticut
$24.9M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$24M -$235K -4,307 -2%
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$23.9M – – –
Verition Fund Management
12
Verition Fund Management
Connecticut
$12.6M +$4.48M +82,005 +141%
BlackRock
13
BlackRock
New York
$7.26M -$273K -5,007 -6%
SCM
14
Suvretta Capital Management
New York
$6.64M – – –
Invesco
15
Invesco
Georgia
$6.52M +$3.95M +72,419 New
Millennium Management
16
Millennium Management
New York
$5.48M +$3.32M +60,894 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$5.24M +$47.3K +867 +2%
MIM
18
Monashee Investment Management
Massachusetts
$4.98M -$1.93M -35,441 -39%
Goldman Sachs
19
Goldman Sachs
New York
$4.07M +$2.47M +45,171 New
ECM
20
ExodusPoint Capital Management
New York
$3.68M +$1.93M +35,292 +629%
Jane Street
21
Jane Street
New York
$2.32M +$1.01M +18,449 +250%
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$2.09M +$1.21M +22,206 +2,210%
Citigroup
23
Citigroup
New York
$1.74M +$125K +2,282 +13%
State Street
24
State Street
Massachusetts
$1.63M +$682K +12,500 +223%
Marshall Wace
25
Marshall Wace
United Kingdom
$1.21M +$732K +13,407 New
1
2 3

KRRO Hedge Fund Activity: Q1 2024 in Review

49 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q1 2024, worth a combined $619M — up 105% from $302M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new KRRO positions and 2 closed out — a net gain of 9 holders — while 12 added to existing stakes and 9 trimmed.

The largest buyer was Verition Fund Management, adding an estimated $4.48M. The largest seller was Monashee Investment Management, cutting an estimated $1.93M.

  • 49 institutional investors held Korro Bio (KRRO) as of Q1 2024, up from 40 in Q4 2023.
  • Funds reported $619M of Korro Bio stock for Q1 2024, up 105% quarter-over-quarter.
  • 11 funds opened new Korro Bio positions in Q1 2024 and 2 closed out, a net change of +9 holders.
  • The largest Korro Bio buyer in Q1 2024 was Verition Fund Management, an estimated $4.48M added.
  • The largest Korro Bio seller in Q1 2024 was Monashee Investment Management, an estimated $1.93M sold.

Based on aggregated 13F filings for Q1 2024.